Publications 2012

  1. Blöcker IM, Dähnrich C, Probst C, Komorowski L, Saschenbrecker S, Schlumberger W, Stöcker W, Zillikens D, Schmidt E. Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid. Br J Dermatol 166(5): 964-970 (2012).
  2. Damoiseaux J, van Rijsingen M, Warnemünde N, Dähnrich C, Fechner K, Cohen Tervaert JW. Autoantibody detection in bullous pemphigoid: Clinical evaluation of the EUROPLUS™ Dermatology Mosaic. J Immunol Methods 382: 76-80 (2012).
  3. Finke C, Kopp UA, Prüss H, Dalmau J, Wandinger KP, Ploner CJ. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry 83(2): 195-8 (2012).
  4. Finke C, Prüss H, Scheel M, Ostendorf F, Harms L, Borowski K, Wandinger KP, Ploner CJ. Anti-NMDA receptor antibodies in a case of MELAS syndrome. J Neurol 259(3): 582-4 (2012).
  5. Groth S, Vafia K. Recke A, Dähnrich C, Zillikens D, Stöcker W, Kuhn A, Schmidt E. Antibodies to the C-terminus of laminin ?1 are present in a distinct subgroup of patients with systemic and cutaneous lupus erythematosus. Lupus 0961203312460113 (2012).
  6. Gunnarsson I, Schlumberger W, Rönnelid J. Antibodies to M-type phospholipase A2 receptor (PLA2R) and membranous lupus nephritis. Am J Kidney Dis 59(4): 582-589 (2012).
  7. Haussleiter IS, Emons B, Schaub M, Borowski K, Brüne M, Wandinger KP, Juckel G. Investigation of antibodies against synaptic proteins in a cross-sectional cohort of psychotic patients. Schizophr Res 140(1-3):25825-9 (2012).
  8. Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, Ziemann U, Kern P, Wandinger KP, Bergh FT, Boettcher T, Langel S, Liebetrau M, Rommer PS, Niehaus S, Münch C, Winkelmann A, Zettl U UK, Metz I, Veauthier C, Sieb JP, Wilke C, Hartung HP, Aktas O, Paul F. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation 9:14 (2012).
  9. Jarius S, Wandinger KP, Borowski K, Stöcker W, Wildemann B. Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature. Clin Neurol Neurosurg 114(4): 331-335 (2012).
  10. Kasperkiewicz M, Dähnrich C, Probst C, Komorowski L, Stöcker W, Schlumberger W, Zillikens D, Rose C. Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides. J Am Acad Dermatol 66(4): 583-588 (2012).
  11. Komorowski L, Müller R, Vorobyev A, Probst C, Recke A, Jonkman MF, Hashimoto T, Kim SC, Groves R, Ludwig RJ, Zillikens D, Stöcker W, Schmidt E. Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. J Am Acad Dermatol 68(3): e89-95 (2012).
  12. Komorowski L, Teegen B, Probst C, Aulinger-Stöcker K, Sina C, Fellermann K, Stöcker W. Autoantibodies against exocrine pancreas in Crohn's disease are directed against two antigens: The glycoproteins CUZD1 and GP2. Journal of Crohn's and Colitis (2012) [Epub ahead of print].
  13. Leypoldt F, Wandinger KP, Voltz R. Neues bei paraneoplastischen Syndromen in der Neurologie. Akt Neurol 39: 60-73 (2012).
  14. Mytilinaiou MG, Meyer W, Scheper T, Rigopoulou EI, Probst C, Koutsoumpas AL, Abeles D, Burroughs AK. Komorowski L, Vergani D, Bogdanos DP. Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis. Clin Chim Acta 413: 1211-1216 (2012).
  15. Probst C, Ott A, Scheper T, Meyer W, Stöcker W, Komorowski. N-terminal disulfide-bridging of Borrelia outer surface protein C increases its diagnostic and vaccine potentials. Ticks and Tick-borne Diseases 3: 1-7 (2012).
  16. Prüss H, Höltje M, Maier N, Gomez A, Buchert R, Harms L, Ahnert-Hilger G, Schmitz D, Terborg C, Kopp U, Klingbeil C, Probst C, Kohler S, Schwab JM, Stöcker W, Dalmau J, Wandinger KP. IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology 78(22): 1743-53 (2012).
  17. Reynders MB, Miendje Deyi VY, Dahma H, Scheper T, Hanke M, Decolvenaer M, Dediste A. Performance of individual Helicobacter pylori antigens in the immunoblot-based detection of H. pylori infection. FEMS Immunol Med Microbiol 64: 352-363 (2012).
  18. Richter T, Bossuyt X, Vermeersch P, Uhlig HH, Stern M, Hauer A, Zimmer KP, Mearin L, de Roo JHC, Dähnrich C, Mothes T. Determination of IgG and IgA antibodies against native gliadin is not helpful in the diagnosis of coeliac disease in children up to two years old. JPGN 55(1):21-25 (2012).
  19. Stöcker W, Schlumberger W. Alle Beiträge zum Thema Autoimmundiagnostik. In: Gressner A, Arndt T (Hrsg.) Lexikon der Medizinischen Laboratoriumsdiagnostik. 2. Aufl., Springer Medizin Verlag, Heidelberg (2012).
  20. van Beek N, Rentzsch K, Probst C, Komorowski L, Kasperkiewiscz M, Fechner K, Zillikens D, Stöcker W, Schmidt E. Serological diagnosis of autoimmune bullous skin diseases: Prospective comparison of the BIOCHIP mosaic-based immunofluorescence technique and the conventional multi-step single test strategy. Orphanet J Rare Dis 7:49 (2012).
  21. Voigt J, Krause C, Rohwäder E, Saschenbrecker S, Hahn M, Danckwardt M, Feirer C, Ens K, Fechner K, Barth E, Martinetz T, Stöcker W. Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells. Clin Dev Immunol (2012).
  1. Bahtz R, Tiede S, Probst C, Meyer W, Stöcker W, Komorowski L. A set of autoantigens associated with paraneoplastic neurological syndrome is commonly expressed in small-cell lung cancer cell lines. 11. Congress of the International Society of Neuroimmunology (ISNI), Boston, USA (2012).
  2. Biesen R, Rose T, Dähnrich C, Dzionek A, Schlumberger W, Radbruch A,Burmester GR,Gruetzkau A, Hiepe F. IFNA and its response proteins IP-10 and SIGLEC1 are biomarkers of present and prospective disease activity in systemic Lupus erythematosus. 8. International Congress on Autoimmunity, Granada, Spain (2012).
  3. Probst C, Teegen B, Bogdanos DP, Stöcker W, Komorowski L. A recombinant cell-based IFA (RC-IFA) for the sensitive determination of autoantibodies against IMPDH2 ("rings and rods"). 63. Annual Congress of the American Association for the Study of Liver Diseases (AASLD), Boston, USA (2012).
  4. Westermann J, Schütt A, Probst C, Schlumberger W, Stöcker W. Autoantibodies against actylcholine receptors in myasthenia gravis: Laboratory diagnosis and follow-up using a new Anti-AChR RIA. 8. International Congress on Autoimmunity, Granada, Spain (2012).
  1. Fechner K. 1. An update on ANCA testing. 2.  Innovative technologies: Designer antigens and RC-IFA. 3. Solutions for IFA automation. 7. Conference of the Autoantibody Network, Mississauga, Canada (2012).
  2. Fechner K. 1. RC-IFT: Neue Forschungsparameter für das Diagnostiklabor. 2. Automatisierungslösungen für die Immunfluoreszenz. 16. Jahrestagung der IGLD, Essen, Germany (2012).
  3. Fechner K. 1. Standardisierung der Immunfluoreszenz. 2.  RC-IFT: Neue Forschungsparameter für das Diagnostiklabor. EUROIMMUN-Seminar "Indirekte Immunfluoreszenz - Gegenwart und Zukunft einer Standardmethode in der Autoimmun-Diagnostik", Innsbruck, Austria (2012).
  4. Komorowski L. Active celiac disease is associated with IgA antibodies against the exocrine pancreatic glycoproteins CUZD1 und GP2. 8. International Congress on Autoimmunity, Granada, Spain (2012).
  5. Schlumberger W. 1. New developments in the serological diagnosis of rheumatic diseases.
    2. PLA2 receptor antibodies in primary and secondary membranous nephritis. Seminar "Lupus in de (laboratorium) praktijk", Nijmegen, Netherlands (2012).
  6. Schlumberger W. Innovative technologies: Designer Antigens and Recombinant Cell-based Immunofluorescence Assays. 7. National Molecular and Diagnostic Microbiology Congress, Ankara, Turkey (2012).
  7. Stöcker W. Recombinant target antigens in the diagnosis of antibodies in autoimmune, infectious and allergic diseases. EUROIMMUN China Customer Summit 2012, Siem Reap, Cambodia (2012).
  8. Stöcker W. Development of test systems to identify autoantibodies against intracellular and superficial onconeuronal antigens: Introduction to neuronal autoantibodies. Symposium (WKBWV/BIOGNOST/EUROIMMUN) "Autoantibodies in Neurology", Kortrijk, Belgium (2012).
  9. Komorowski L. Development of test systems to identify autoantibodies against intracellular and superficial onconeuronal antigens: Biochemial assays for neuronal autoantibodies and their limitations. Symposium (WKBWV/BIOGNOST/EUROIMMUN) "Autoantibodies in Neurology", Kortrijk, Belgium (2012).
  10. Probst C. Development of test systems to identify autoantibodies against intracellular and superficial onconeuronal antigens: Recombinant cell-based immunofluorescence assays for fast evaluation of novel autoantigens and routine diagnostics. Symposium (WKBWV/BIOGNOST/EUROIMMUN) "Autoantibodies in Neurology", Kortrijk, Belgium (2012).
  11. Saschenbrecker S. Development of test systems to identify autoantibodies against intracellular and superficial onconeuronal antigens: Recent studies on novel autoantibodies. Symposium (WKBWV/BIOGNOST/EUROIMMUN) "Autoantibodies in Neurology", Kortrijk, Belgium (2012).
  12. Rentzsch K. Development of test systems to identify autoantibodies against intracellular and superficial onconeuronal antigens: Handling of novel neuronal autoantibodies in the daily laboratory practice. Symposium (WKBWV/BIOGNOST/EUROIMMUN) "Autoantibodies in Neurology", Kortrijk, Belgium (2012).
  1. Kalibrationsstreifen für einen Immunoblot. German utility patent application DE 20 2011 106 093 (filed 2011).
  2. Morrin M. Vorrichtung und Verfahren zur automatischen Fokussierung für die Mikroskopie schwach leuchtender Substrate. German and International patent application DE 10 2010 035 104.0 (filed 2010) and WO 2012/025220 (filed 2011).
  3. Objektträger. German utility patent application DE 20 2011 005 278 (filed 2011)
  4. Stöcker W, Ehling T. Vorrichtung und Verfahren zur Untersuchung einer biologischen Probe. German patent application DE 10 2011 011 795.4 (filed 2011)
  5. Stöcker W, Komorowski L, Probst C, Janssen A. Polypeptides and method for the specific detection of antibodies in patients with a Borrelia infection. US patent application US 2012 0177680 (filed 2012).
  6. Stöcker W, Wandinger KP. Verfahren zum Nachweis von Anti-NMDA-Rezeptor-Autoantikörpern zum Einsatz in Diagnoseverfahren. German and International patent application DE 10 2010 053 432.3 (filed 2010) and WO 2012/076000 (filed 2011).
  7. Stöcker W. Diagnosekit sowie Verfahren zur Untersuchung einer menschlichen Patientenprobe auf das Vorhandensein Neuromyelitis-optica-spezifischen Antikörpern. German and International patent application DE 10 2011 011 280.4 (filed 2011) and WO 2012/110024 (filed 2012).
  8. Testkit für die Labordiagnostik. German utility patent application DE 20 2012 004 404 (filed 2012).